Insight Molecular Diagnostics (IMDX) Other Working Capital Changes (2016 - 2026)
Insight Molecular Diagnostics' Other Working Capital Changes history spans 6 years, with the latest figure at $102000.0 for Q4 2025.
- On a quarterly basis, Other Working Capital Changes rose 115.84% to $102000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $226000.0, a 177.66% increase, with the full-year FY2025 number at $226000.0, up 177.66% from a year prior.
- Other Working Capital Changes hit $102000.0 in Q4 2025 for Insight Molecular Diagnostics, up from -$65000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for IMDX hit a ceiling of $795000.0 in Q3 2022 and a floor of -$861000.0 in Q4 2022.
- Historically, Other Working Capital Changes has averaged -$59600.0 across 5 years, with a median of -$31500.0 in 2023.
- The widest YoY moves for Other Working Capital Changes: up 1304.0% in 2022, down 614.1% in 2022.
- Tracing IMDX's Other Working Capital Changes over 5 years: stood at -$396000.0 in 2021, then plummeted by 117.42% to -$861000.0 in 2022, then surged by 83.86% to -$139000.0 in 2023, then plummeted by 363.31% to -$644000.0 in 2024, then surged by 115.84% to $102000.0 in 2025.
- Business Quant data shows Other Working Capital Changes for IMDX at $102000.0 in Q4 2025, -$65000.0 in Q3 2025, and $219000.0 in Q2 2025.